Axsome Therapeutics

Summary

Axsome Therapeutics is a business^[1].

Key Facts

• Axsome Therapeutics is in the country of United States^[2].
• Axsome Therapeutics is in the country of US^[3].
• Axsome Therapeutics's instance of is recorded as business^[4].
• Axsome Therapeutics's headquarters location is recorded as New York City^[5].
• Axsome Therapeutics's stock exchange is recorded as Nasdaq^[6].
• January 1, 2012 marks the founding of Axsome Therapeutics^[7].
• 2012-01-12 marks the founding of Axsome Therapeutics^[8].
• Axsome Therapeutics's coordinate location is recorded as {'globe': 'http://www.wikidata.org/entity/Q2', 'altitude': None, 'latitude': 40.710445, 'longitude': -74.010604, 'precision': 1e-06}^[9].
• Axsome Therapeutics's official website is recorded as https://axsome.com/^[10].
• Axsome Therapeutics's legal form is recorded as XTIQ^[11].

Product Details

The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.

GLEIF Golden Copy — Level 1 entity data

• Legal Entity Identifier (LEI): 549300EXGR0XLRJEIB95^[12]

• Registered legal name: Axsome Therapeutics, Inc.^[13]

• Legal jurisdiction: US-DE^[14]

• GLEIF entity category: GENERAL^[15]

• Legal form (ISO 20275 ELF): XTIQ^[16]

• Entity status: ACTIVE^[17]

• LEI registration status: LAPSED^[18]

• Entity created: 2012-01-12^[19]

• LEI first registered: 2015-10-08^[20]

• LEI last updated: 2026-07-31^[21]

• LEI next renewal: 2017-11-18^[22]

• Managing LOU: 5493001KJTIIGC8Y1R12^[23]

• Registration authority: RA000602^[24]

• Authority entity ID: 5091162^[25]

• Conformity flag: NON_CONFORMING^[26]

Body

Founding

Recorded inception include January 1, 2012^[7] and 2012-01-12^[8].

Operations

Axsome Therapeutics's headquarters location is recorded as New York City^[5].

Ownership

Axsome Therapeutics's stock exchange is recorded as Nasdaq^[6].